[Munich, October 22nd] – Adragos Pharma, a global Contract Development and Manufacturing Organization (CDMO), is proud to announce its participation in the Science Based Targets initiative (SBTi), marking a significant commitment to environmental sustainability and corporate responsibility in the fight against climate change.
As a leader in pharmaceutical development and manufacturing, we have always prioritized innovation and efficiency. By joining the SBTi, we are now aligning our operations with the imperative to reduce greenhouse gas (GHG) emissions in accordance with the latest climate science.
Understanding the SBTi
The Science Based Targets initiative is a partnership between CDP, the United Nations Global Compact, the World Resources Institute (WRI), the World Wide Fund for Nature (WWF), and the We Mean Business Coalition. It is dedicated to driving ambitious corporate climate action through science-based target setting. Companies and financial institutions around the world rely on the SBTi to guide them in setting necessary GHG emissions reductions targets to prevent the worst effects of climate change.
Our Commitment
By committing to the SBTi, Adragos commits to set long-term science-based targets to reach net-zero value chain GHG emissions by no later than 2050 in line with the SBTi Net-Zero Standard and submit it for SBTi validation within a maximum of 24 months. By committing to set a net-zero target, Adragos acknowledges that it joins the Race to Zero campaign. This commitment not only reflects our responsibility to the planet but also to our customers, employees, and shareholders who expect sustainability to be at the core of our operations.
Commenting on this milestone, our COO, Marco Gorgas, stated,
By joining the Science Based Targets initiative, Adragos is taking a decisive step forward, not merely committing to sustainability, but actively advocating for it. In the CDMO industry, we have a pivotal role in shaping sustainable practices. Our commitment extends beyond compliance; it is about setting a precedent that integrates environmental stewardship directly into our core business strategies, inspiring industry-wide change and ensuring a healthier planet for future generations.
Our Sustainable Future
As we continue to expand our global footprint, embracing sustainability remains a cornerstone of our strategy. The commitment to the SBTi is part of a broader approach to ensure that our operations contribute positively to our environmental responsibilities. We are setting an example in the pharmaceutical industry by proving that business growth and environmental stewardship can go hand in hand.
A Call to Action
Adragos participation in the SBTi is just the beginning of our renewed focus on environmental stewardship. Adragos calls on our partners, suppliers, and peers within the pharmaceutical industry to join us in this crucial initiative. Together, we can make a significant impact on our planet’s health and ensure a sustainable future for all.
